Latest filing published 21 Sept 2023 for Angiodynamics INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Scott Centea: trading record in brief
This profile gathers the share dealings of Scott Centea in Angiodynamics Inc, where the filings describe the role as senior executive. We count 19 filings; the first trade dates from 31 October 2020 and the latest from 21 July 2023.
No open-market purchase appears, only 1 sale worth €289k. The rest of the record consists of 15 share grants and 3 option exercises.
Most recently, on 21 September 2023, the filings show a share grant worth €22k in Angiodynamics Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott Centea
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,539 shares0Common StockSEC:0001140361-23-044837:0
- 3,415 shares0Common StockSEC:0001140361-23-036319:0
- 333 shares@ US$8.740.6% of flowCommon StockSEC:0001140361-23-036118:0
- 255 shares@ US$8.650.4% of flowCommon StockSEC:0001140361-23-036118:1
- 10,588 shares0Common StockSEC:0001140361-23-035727:0
- 517 shares@ US$9.631.0% of flowCommon StockSEC:0001140361-23-035084:0
- 351 shares@ US$9.560.7% of flowCommon StockSEC:0001140361-23-035084:1
- 3,705 shares0Common StockSEC:0001567619-22-014365:0
- 953 shares@ US$29.3710.4% of flowCommon StockSEC:0001567619-21-019404:0
- 12,000 shares@ US$16.7775.5% of flowCommon StockSEC:0001567619-21-018407:0
- 419 shares@ US$26.104.0% of flowCommon StockSEC:0001567619-21-014064:0
- 500 shares@ US$26.434.9% of flowCommon StockSEC:0001567619-21-013923:0
12 of 12 declarations
